Risk factors for chronic renal dysfunction in cardiac allograft recipients

被引:33
|
作者
Esposito, C
Semeraro, L
Bellotti, N
Fasoli, G
Fornoni, A
Rampino, T
Klersy, C
Campana, C
Gavazzi, A
Viganò, M
Dal Canton, A
机构
[1] Univ Pavia, IRCCS, Policlin San Matteo, Dept Internal Med & Nephrol, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiac Surg, I-27100 Pavia, Italy
[4] Univ Pavia, IRCCS, Policlin San Matteo, Sci Adm, I-27100 Pavia, Italy
来源
NEPHRON | 2000年 / 84卷 / 01期
关键词
cardiac allograft recipients; renal function; heart transplantation; ciclosporin;
D O I
10.1159/000045534
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction is one of the most common and threatening complications in heart transplant recipients. Even if ciclosporin seems to play a central role in inducing renal damage, other factors may concur or predispose to renal injury. In order to identify factors responsible for renal dysfunction, we retrospectively studied a cohort of 114 cardiac transplant recipients during a follow-up period of at least 3 years. The patients had a normal renal function before and 0.5 months after heart transplantation. Doubling of baseline serum creatinine or attainment of serum creatinine steadily above 176.8 mu mol/l (2.0 mg/dl) was used as criterion to define the end-point renal dysfunction. A series of clinical and laboratory variables were obtained from the patients' charts at different time intervals, and their prognostic value for the occurrence of renal dysfunction was calculated by Cox proportional hazards models. 23 out of 114 patients reached the end point after a median time period of 21 months. High serum triglyceride, alanine aminotransferase, alkaline phosphatase, ciclosporin, urea, glucose, and hemoglobin levels were shown to be associated with the development of renal dysfunction. Four variables, i.e., triglyceride, ciclosporin, urea, and alkaline phosphatase, had an independent prognostic value. Our results confirm a role for ciclosporin in inducing renal dysfunction and identify hyperlipidemia and an increased plasma urea level as risk factors for renal dysfunction in heart transplant recipients. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [21] Causes of late renal allograft loss: Chronic allograft dysfunction, death, and other factors
    Kreis, HA
    Ponticelli, C
    TRANSPLANTATION, 2001, 71 (11) : SS5 - SS9
  • [22] Re: Bladder Cancer in Renal Allograft Recipients: Risk Factors and Outcomes
    Yakupoglu, Y. Kamil
    JOURNAL OF UROLOGICAL SURGERY, 2015, 2 (02): : 106 - 106
  • [23] Metabolic abnormalities in renal transplant recipients. Risk factors and predictors of chronic graft dysfunction?
    Dimeny, E
    Fellstrom, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (01) : 21 - 24
  • [24] Surrogate markers and risk factors for chronic lung allograft dysfunction
    Bowdish, ME
    Arcasoy, SM
    Wilt, JS
    Conte, JV
    Davis, RD
    Garrity, ER
    Hertz, ML
    Orens, JB
    Rosengard, BR
    Barr, ML
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (07) : 1171 - 1178
  • [25] CYCLOSPORINE INDUCED RENAL DYSFUNCTION IN RENAL-ALLOGRAFT RECIPIENTS
    KIBERD, B
    KIDNEY INTERNATIONAL, 1989, 35 (01) : 517 - 517
  • [26] Renal dysfunction in pediatric liver transplantation recipients: Risk factors
    Mourier, Olivia
    Bernard, Olivier
    Gauthier, Frederic
    Debray, Dominique
    TRANSPLANT INTERNATIONAL, 2007, 20 : 81 - 81
  • [27] Risk factors for renal dysfunction in liver transplant recipients.
    Pawarode, A
    Fine, D
    Yoo, HY
    Thuluvath, PJ
    HEPATOLOGY, 2002, 36 (04) : 227A - 227A
  • [28] Serum cystatin C as a good predictor of chronic allograft dysfunction in renal transplant recipients
    Leawseng, Sirilak
    Satirapoj, Bancha
    Nata, Naowanit
    Supaporn, Thanom
    Ruangkanchanasetr, Prajej
    TRANSPLANTATION, 2016, 100 (07) : S627 - S627
  • [29] Clinical Implications of Proteinuria in Renal Transplant Recipients Switching to Rapamycin for Chronic Allograft Dysfunction
    Gutierrez, M. J.
    Gonzalez, E.
    Andres, A.
    Morales, J. M.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2348 - 2350
  • [30] HISTOLOGICAL ASSESSMENT AFTER EVEROLIMUS RESCUE OF CHRONIC ALLOGRAFT DYSFUNCTION IN RENAL TRANSPLANT RECIPIENTS
    Kwan, Bonnie Ching-Ha
    Chow, Kai Ming
    Szeto, Cheuk Chun
    Lai, Fernand Mac-Moune
    Luk, Cathy Choi-Wan
    Leung, Chi Bon
    Li, Philip Kam-Tao
    TRANSPLANT INTERNATIONAL, 2015, 28 : 425 - 425